Tag: tuberculosis diagnostics market analysis

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Tuberculosis Diagnostics Market Expected To Grow In Terms Of Size?
In recent times, there has been a notable growth in the size of the tuberculosis diagnostics market. The market, which stood at $2.21 billion in 2024, is anticipated to increase to $2.34 billion in 2025, evidencing a compound annual growth rate (CAGR) of 5.9%. The historical growth of this market can be traced back to the escalation in tuberculosis cases, augmentation in healthcare expenditure, expansion in healthcare facilities, and an upward trend in the uptake of nucleic acid testing.

Expectations are high for the tuberculosis diagnostics market to experience significant growth in the coming years, with a projection to reach $3.15 billion in 2029 and a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this predicted surge include robust government backing, an upsurge in FDA approvals for tuberculosis diagnostics, intensified research and development efforts, and the emergence of drug-resistant TB. The upcoming trends forecasted for this period comprise the utilization of next-generation sequencing (NGS) platforms for TB diagnostics, innovative products, t-cell tests for TB infection, artificial intelligence-powered tuberculosis diagnostics, deployment of portable devices, and synergies between government entities and manufacturers.

Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

What Market Forces Are Contributing To The Growth Of The Tuberculosis Diagnostics Market?
The tuberculosis diagnostics market is experiencing an upward trend due to the escalating incidence of tuberculosis. Being an infectious ailment, tuberculosis majorly attacks the lungs and can escalate to extreme conditions. Tuberculosis proliferates through the act of coughing and sneezing, which disperse microscopic germs in the air. These diagnostic tools for tuberculosis significantly contribute to patient detection, endorsing earlier diagnoses and detection of ailments. As an exemplification, the Centers for Disease Control and Prevention, a significant public health institution based in the US, reported in March 2023 that there were 8,300 instances of tuberculosis in the US in 2022, marking an increase from the 7,874 cases of 2021. Consequently, this surge in tuberculosis occurrence bolsters the expansiveness of the tuberculosis diagnostics market. Hence, the growing prevalence of tuberculosis is propelling the development of the tuberculosis diagnostics market.

How Is The Tuberculosis Diagnostics Market Segmented Across Key Categories?
The tuberculosis diagnosticsmarket covered in this report is segmented –

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:
1) By Radiographic Tests: Chest X-rays, CT Scans
2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)
3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays
5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
6) By Blood Or Serology Test: Serological Tests for Antibodies
7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures
9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

What Key Trends Are Driving Growth In The Tuberculosis Diagnostics Market?
The tuberculosis diagnostics market is seeing a growing trend in technological advancements. High-profile businesses in the market are leveraging cutting-edge technologies like AI-based point-of-care (POC) diagnostics to maintain their market dominance. Notably, in August 2022, Fujifilm, a Japanese firm specializing in the production of medical imaging devices, collaborated with Qure.ai, an American company known for creating AI-powered medical imaging solutions. Their joint venture resulted in an advanced POC diagnostic methodology which employs a battery-operated X-ray machine for diagnosing tuberculosis. Propped up by artificial intelligence, these algorithms enhance the testing programs by providing highly portable, accurate, and effective POC diagnostic options.

Who Are The Major Stakeholders Operating In The Tuberculosis Diagnostics Market?
Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di’an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

How Do Regional Dynamics Influence The Tuberculosis Diagnostics Market Performance?
Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=8165&type=smp

Browse Through More Reports Similar to the Global Tuberculosis Diagnostics Market 2025, By The Business Research Company

Respiratory Disposables Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report

Respiratory Devices And Equipment Therapeutic Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Tuberculosis Diagnostics Market Growth Evolved From 2024 To 2025, And What’s Ahead?

There has been significant growth in the tuberculosis diagnostics market size over the recent years. A rise from $2.21 billion in 2024 to $2.34 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%, is predicted. This market’s growth during the historic period is due to factors such as the surge in tuberculosis cases, increment in healthcare spending, expansion of healthcare facilities, and a growing acceptance of nucleic acid testing.

The market size for tuberculosis diagnostics is projected to experience significant expansion in the coming years. By 2029, it is anticipated to reach $3.15 billion, with a compound annual growth rate (CAGR) of 7.7%. This growth over the forecast period can be credited to robust governmental backing, an increase in FDA approvals for tuberculosis diagnostics, a surge in research and development (R&D) activities, and the emergence of drug-resistant TB. Key trends within the forecasted period encompass attention towards next-generation sequencing (NGS) platforms for TB diagnostics, advancements in product innovations, t-cell tests for TB infection, deployments of artificial intelligence (AI) for tuberculosis diagnostics, portable device utilization, and partnerships between governments and manufacturers.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

What Are the Core Market Drivers Propelling Growth in the Tuberculosis Diagnostics Industry?

The escalating occurrence of tuberculosis propels the need for the tuberculosis diagnostics market. Tuberculosis, a potentially severe infectious ailment primarily affecting the lungs, spreads via airborne transmission from coughing and sneezing. To spot patients faster and detect the disease earlier, tuberculosis diagnostics are crucial. For example, data from the Centers for Disease Control and Prevention, a public health organization based in the U.S., indicates that there were 8,300 reported tuberculosis cases in the U.S. in March 2023, up from 7,874 cases in 2021. Consequently, the upward trend in tuberculosis occurrences propels the demand in the tuberculosis diagnostics market. Hence, this increasing prevalence of tuberculosis is the driving force behind the expansion of the tuberculosis diagnostics market.

How Is the Tuberculosis Diagnostics Market Segmented?

The tuberculosis diagnosticsmarket covered in this report is segmented –

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types

2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis

3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:

1) By Radiographic Tests: Chest X-rays, CT Scans

2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)

3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)

4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays

5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)

6) By Blood Or Serology Test: Serological Tests for Antibodies

7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test

8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures

9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8165&type=smp

Which Regions Are Driving the Next Phase of the Tuberculosis Diagnostics Market Growth?

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Tuberculosis Diagnostics Industry?

Technological advancements form a prevalent trend in the tuberculosis diagnostics market, with major market players introducing new tech such as AI-based Point-of-Care (POC) diagnostics. For example, Fujifilm, a Japan-based medical imaging devices firm, teamed up with Qure.ai, a US-based developer of AI medical imaging solutions in August 2022. Together, they introduced an enhanced POC diagnostic approach, deploying a battery-operated X-ray machine for diagnosing tuberculosis. The use of AI and its algorithms ensures effective testing, ultra-portability, high precision, and efficient POC diagnostic solutions.

View the full report here:

https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

How Is the Tuberculosis Diagnostics Market Defined and What Are Its Core Parameters?

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for TB diagnosis and tracking the effectiveness of treatment. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8165

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Tuberculosis Diagnostics Market Grown from 2024 to 2025?

In recent times, the tuberculosis diagnostics market has seen significant expansion. The market value is projected to increase from $2.21 billion in 2024 to $2.36 billion in 2025, growing at a compound annual growth rate (CAGR) of 6.9%. Factors that have contributed to this growth during the historic period include a surge in tuberculosis cases, escalated spending in healthcare, an increase in healthcare facilities and heightened acceptance of nucleic acid testing.

What Growth Rate Is Anticipated for the Tuberculosis Diagnostics Market in the Coming Years?

Strong growth is projected for the tuberculosis diagnostics market in the coming years, with the market size expected to reach $3.24 billion in 2029, reflecting a compound annual growth rate (CAGR) of 8.2%. Factors contributing to this projected expansion in the forecast period include robust governmental backing, escalating FDA validations for tuberculosis diagnostics tools, burgeoning research and development (R&D) endeavours, and the rise of drug-resistant TB. The forecast period is likely to witness notable trends such as the increasing emphasis on next-generation sequencing (NGS) platforms for TB diagnostics, advancements in product innovation, the incorporation of t-cell tests for detecting TB infection, the application of artificial intelligence (AI) in tuberculosis diagnostics, utilization of portable gadgets, and governmental partnerships with manufacturers.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

Who Are the Leading Companies in the Tuberculosis Diagnostics Market?

Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di’an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

What Are the Key Drivers of the Tuberculosis Diagnostics Market?

The demand for the tuberculosis diagnostics market is being propelled by the increasing occurrence of tuberculosis. As a severe infectious disease, tuberculosis primarily impacts the lungs and is transmitted through coughing and sneezing, as these actions disperse small germs into the air. The role of tuberculosis diagnostics is vital in facilitating early identification and detection of the disease. For example, the Centers for Disease Control and Prevention, a national public health organization based in the US, reported in March 2023 that 8,300 cases of tuberculosis were identified in the US in 2022, marking an increase from 7,874 cases in 2021. Consequently, the escalating incidence of tuberculosis is fuelling the growth of the tuberculosis diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8165&type=smp

What Are the Key Market Segments in the Tuberculosis Diagnostics Industry?

The tuberculosis diagnostics market covered in this report is segmented –

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types

2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis

3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:

1) By Radiographic Tests: Chest X-rays, CT Scans

2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)

3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)

4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays

5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)

6) By Blood Or Serology Test: Serological Tests for Antibodies

7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test

8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures

9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

What Are the Latest Trends in the Tuberculosis Diagnostics Market?

Technological advancements are becoming an emerging trend in the tuberculosis diagnostics market. Leading corporations in this market are integrating new technologies like advanced point-of-care (POC) diagnostic techniques, underpinned by AI technology, to maintain their market dominance. For example, Fujifilm, a Japanese firm specializing in the production of medical imaging equipment, partnered with Qure.ai, a U.S.-based firm developing AI-driven medical imaging solutions in August 2022. They unveiled an innovative point-of-care (POC) diagnostic approach, utilising a battery-powered X-ray machine for tuberculosis diagnosis. The incorporation of artificial intelligence enhances the efficiency of testing programs with high precision, impressive portability and efficient point-of-care diagnostic solutions.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

What Are the Key Regional Markets in the Tuberculosis Diagnostics Industry?

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8165

This Report Delivers Insight On:

1. How big is the tuberculosis diagnostics market, and how is it changing globally?

2. Who are the major companies in the tuberculosis diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the tuberculosis diagnostics market right now?

4. Which products or customer segments are growing the most in the tuberculosis diagnostics market?

5. What factors are helping or slowing down the growth of the tuberculosis diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the tuberculosis diagnostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Tuberculosis Diagnostics Market Size Shifted, And What Is the Outlook Through 2034?

In recent times, the tuberculosis diagnostics market has witnessed significant growth. The size of the market will escalate from $2.21 billion in 2024 to $2.36 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. The surge in historic growth is due to various factors such as the increasing occurrence of tuberculosis, enhanced expenditure in healthcare, expansion in the quantity of healthcare facilities, and the increasing adoption of nucleic acid testing.

The market for tuberculosis diagnostics is predicted to experience substantial expansion in the upcoming years, escalating to a value of $3.24 billion in 2029, representing a compound annual growth rate (CAGR) of 8.2%. The predicted growth within this period is largely due to robust governmental backing, rising numbers of FDA approvals specific to tuberculosis diagnostics, an upsurge in research and development (R&D) endeavors, and the advent of drug-resistant TB. The forecast period is anticipated to see trends such as a greater emphasis on next-generation sequencing (NGS) platforms for TB diagnostics, advancements in product innovations, t-cell tests for identifying TB infection, the incorporation of artificial intelligence (AI) in tuberculosis diagnostics, the utilization of portable devices, and cooperative efforts between government entities and manufacturers.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theTuberculosis Diagnostics Market?

An increase in tuberculosis cases is propelling the need for tuberculosis diagnostics forward. Tuberculosis, an infectious disease mainly impacting the lungs, can be quite intense. It transmits via coughing and sneezing, which spreads small germs into the air. Diagnostics for tuberculosis aid in identifying the disease in patients earlier leading to better detection. For example, the Centers for Disease Control and Prevention, an important public health organization in the US, reported 8,300 tuberculosis cases in March 2023, reflecting a hike from 7,874 cases in 2021. This spike in tuberculosis occurrence fuels the tuberculosis diagnostics market, consequently, this escalation in tuberculosis occurrence is fostering the expansion of the tuberculosis diagnostics market.

Which Segments in the Tuberculosis Diagnostics Offer the Most Growth?

The tuberculosis diagnostics market covered in this report is segmented –

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types

2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis

3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:

1) By Radiographic Tests: Chest X-rays, CT Scans

2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)

3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)

4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays

5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)

6) By Blood Or Serology Test: Serological Tests for Antibodies

7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test

8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures

9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8165&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theTuberculosis Diagnostics Market?# Market?

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Tuberculosis Diagnostics Industry?

Technological advancements mark a major trend taking hold in the tuberculosis diagnostics market. To solidify their market standing, key businesses in the sector are unveiling novel technologies, such as advanced point-of-care (POC) diagnostic techniques harnessing the power of AI. As an example, Fujifilm, a leading medical imaging devices manufacturer based in Japan, entered a collaboration with Qure.ai, an American firm specializing in the creation of AI-powered medical imaging solutions, in August 2022. They launched a sophisticated point-of-care (POC) diagnostic technique that utilizes a battery-operated X-ray machine for diagnosing tuberculosis. Artificial intelligence underpins algorithms in effective diagnostic programs, providing ultra-mobility, high precision, and efficient point-of-care diagnostic solutions.

View the full report here:

https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

What Are the Key Elements That Define the Tuberculosis Diagnostics Market?

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for TB diagnosis and tracking the effectiveness of treatment. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8165

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theTuberculosis Diagnostics Market?

The tuberculosis diagnostics market is witnessing an upward trend owing to a surge in the occurrence of tuberculosis. Being a contagious ailment, tuberculosis majorly impacts the lungs and can have severe effects. It spreads via coughing or sneezing, expelling minute germs in the air. Tuberculosis diagnostics play a pivotal role in detecting diseases in patients at an early stage. For instance, the Centers for Disease Control and Prevention, a prominent U.S.-based public health agency, reported that the number of tuberculosis (TB) cases in the United States rose to 8,300 in March 2023, an increase from 7,874 cases in 2021. Consequently, the escalating incidence of tuberculosis fuels the demand in the tuberculosis diagnostics market. Hence, the rising prevalence of tuberculosis is driving the expansion of the tuberculosis diagnostics market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

#How Does the ProjectedTuberculosis Diagnostics Market Growth Compare Over the Forecast Period?

In recent years, the market size for tuberculosis diagnostics has seen robust growth. The market is forecasted to expand from $2.21 billion in 2024 to $2.36 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. The growth observed in the past is due to factors such as the increase in tuberculosis cases, heightened healthcare spending, an increased number of healthcare facilities, and a surge in the uptake of nucleic acid testing.

Expectations are high for substantial growth within the tuberculosis diagnostics market in the coming years. It is predicted to surge to a total of $3.24 billion by 2029, showcasing a compound annual growth rate (CAGR) of 8.2%. This projected growth in the forecast period is likely due to various factors such as robust government backing, escalating FDA approvals specifically for tuberculosis diagnostics, increase in research and development (R&D) efforts, and the rise of medication-resistant tuberculosis. Upcoming trends to watch encompass a concentration on next-generation sequencing (NGS) for TB diagnosis, innovative products, T-cell testing for TB infection, AI-driven tuberculosis diagnostics, adoption of portable devices, and enhanced collaborations amongst governments and manufacturers.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8165

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theTuberculosis Diagnostics Market?

Technological advancements are emerging as a prominent trend in the tuberculosis diagnostics market. Major players in the market are leveraging new technologies, such as advanced point-of-care (POC) diagnostic techniques that are based on AI technology, to maintain market dominance. For example, in August 2022, Fujifilm, a Japanese company specializing in the creation of medical imaging devices, teamed up with Qure.ai, a US company that develops AI-powered medical imaging solutions. Together, they introduced an advanced point-of-care (POC) diagnostic method. In this method, a battery-powered X-ray machine is utilized for tuberculosis diagnosis. Through the application of artificial intelligence, algorithms facilitate efficient testing programs while providing ultra-portability, high precision, and effective point-of-care diagnostic solutions.

Who Are the Key Market Players Influencing the Growth of the Corn and Tuberculosis Diagnostics Industry?

Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di’an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

Which Key Market Segments Comprise the Tuberculosis Diagnostics Market and Drive Its Revenue Growth?

The tuberculosis diagnostics market covered in this report is segmented –

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types

2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis

3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:

1) By Radiographic Tests: Chest X-rays, CT Scans

2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)

3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)

4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays

5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)

6) By Blood Or Serology Test: Serological Tests for Antibodies

7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test

8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures

9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=8165&type=smp

Which Regions Are Emerging as Leaders in the Tuberculosis Diagnostics Market?

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Tuberculosis Diagnostics Market 2025, By The Business Research Company:

Chartered Air Transport Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chartered-air-transport-global-market-report

Truck Transportation Global Market Report 2019 _x000D_

Including: General Freight Trucking, Specialized Freight Trucking Local General Freight Trucking, Long-Distance General Freight Trucking , Automobiles And Heavy Equipment, Bulk Liquids, Dry Bulk Materials, Forest Products, Refrigerated Goods_x000D_

Covering: C.H. Robinson, J.B. Hunt Transport Services, YRC Freight, Swift Transportation, Landstar_x000D_

https://www.thebusinessresearchcompany.com/report/truck-transportation-global-market-report

Passenger Air Transport Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/passenger-air-transport-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the tuberculosis diagnostics market size evolved in recent years?

The market size for tuberculosis diagnostics has seen robust growth in the past few years. It’s expected to increase from $2.21 billion in 2024 to approximately $2.36 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this growth during the historic period include a surge in tuberculosis cases, augmented healthcare spending, an expansion in the number of healthcare facilities, and an increased uptake of nucleic acid testing.

What are the predictions for the tuberculosis diagnostics market size in the coming years?

The e-commerce market for pet care is predicted to undergo swift expansion in the forthcoming years. It’s anticipated to escalate to a value of $54.25 billion by 2029, with a compound annual growth rate (CAGR) of 11.9%. The growth during the forecast period can be ascribed to factors such as the preference for subscription-based models, increased automation, growing trend towards eco-friendly pet care, a surge in online veterinary consultations, and the universal expansion of e-commerce. Notable trends for the forecast period encompass health tracking wearables, virtual pet adoption, subscription-based pet food services, inventive packaging, and do-it-yourself pet grooming kits.

Get your tuberculosis diagnostics market report here!

https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

What key factors are fueling the growth of the tuberculosis diagnostics market?

The escalating occurrence of tuberculosis is propelling the need for tuberculosis diagnostics in the medical sector. Tuberculosis is a potentially serious respiratory infection, communicable through coughing or sneezing which discharges tiny germs into the air. This further emphasizes the importance of tuberculosis diagnostic tools in early detection and management of this disease. The Centers for Disease Control and Prevention, a reputable public health organization in the US, reported 8,300 cases of tuberculosis in March 2023, a noteworthy increase from 7,874 cases reported in 2021. This growing presence of tuberculosis therefore, fuels the demand for the tuberculosis diagnostics market. Hence, the increasing frequency of tuberculosis is stimulating the expansion of the tuberculosis diagnostics market.

How is the global tuberculosis diagnostics market divided into key segments?

The tuberculosis diagnostics market covered in this report is segmented –

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types

2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis

3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:

1) By Radiographic Tests: Chest X-rays, CT Scans

2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)

3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)

4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays

5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)

6) By Blood Or Serology Test: Serological Tests for Antibodies

7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test

8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures

9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

Who are the key firms paving the way for growth in the tuberculosis diagnostics market?

Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di’an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio

Which trends are expected to transform the tuberculosis diagnostics market?

The tuberculosis diagnostics market is seeing a surge in technological advancements, which is emerging as a key trend. To maintain their market standing, top companies are unveiling new technologies like enhanced point-of-care (POC) diagnostic techniques incorporating AI technology. For instance, Fujifilm, a Japanese enterprise specializing in the production of medical imaging devices, teamed up with Qure.ai, a U.S. based firm that develops AI-enabled medical imaging solutions, in August 2022. They rolled out an innovative POC diagnostic technique that utilizes a battery-driven X-ray machine for diagnosing tuberculosis. Using AI, these algorithms facilitate proficient testing programs and provide ultra-portable, highly precise and efficient point-of-care diagnostic solutions.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8165

What regions are contributing significantly to the growth of the tuberculosis diagnostics market?

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Respiratory Disposables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report

Transplant Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Molecular Diagnostics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Significant is the Anticipated Growth Rate of the Tuberculosis Diagnostics Market from 2025 to 2034?

Over the past few years, the tuberculosis diagnostics market has been expanding significantly. The market is projected to escalate from $2.21 billion in 2024 to $2.36 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. The historical growth in the market is linked to several factors such as the increasing occurrence of tuberculosis, additional healthcare spending, the expansion in the quantity of healthcare centers, and the growing adoption of nucleic acid testing.

The market size of tuberculosis diagnostics is poised for robust expansion in the coming years, projecting a growth to $3.24 billion by 2029 with a compound annual growth rate (CAGR) of 8.2%. The development in the anticipated span is due to considerable government backing, an upsurge in FDA endorsements for tuberculosis testing methods, an increase in research and development activities, and the advent of drug-resistant tuberculosis. Key forward-looking trends include the emphasis on next-generation sequencing platforms for TB detection methods, product advancements, t-cell examinations for TB infection, application of artificial intelligence in TB testing, utilization of portable gadgets, and partnerships formed between public administration and manufacturers.

What Strategic Factors Are Influencing the Accelerated Growth of the tuberculosis diagnostics Market?

An increase in tuberculosis incidents is propelling the demand for the tuberculosis diagnostics market. Being a contagious disease affecting the lungs and capable of becoming severe, tuberculosis spreads via coughing and sneezing, propelling tiny germs into the air. Tuberculosis diagnostics facilitate detection of patients, promoting early diagnosis and disease detection. For example, the Centers for Disease Control and Prevention, a US-based national public health organization, reported that in the United States, there were 8,300 cases of tuberculosis (TB) in 2022, an increase from 7,874 cases in 2021, in March 2023. This increase in tuberculosis incidence is therefore driving the tuberculosis diagnostics market. Hence, the increasing occurrence of tuberculosis is fostering the expansion of the tuberculosis diagnostics market.

Request Your Free Tuberculosis Diagnostics Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp

Who Are the Dominant Players Pushing the Boundaries of the Tuberculosis Diagnostics Market?

Major companies operating in the tuberculosis diagnostics market include:

• Beckton_x000D_

• Dickinson and Company_x000D_

• F. Hoffmann-La Roche Ltd_x000D_

• Qiagen N.V_x000D_

• BioMerieux SA_x000D_

How Are Market Trends Revolutionizing the Tuberculosis Diagnostics Industry in Recent Times?

The rising trend in the tuberculosis diagnostics market is predominantly driven by technological advancements. To maintain their market standing, key players in the sector are adopting novel technologies like cutting-edge point-of-care (POC) diagnostic procedures that utilize AI. For instance, Fujifilm – a Japanese company specializing in the production of medical imaging equipment – joined hands with Qure.ai, a US-based company focusing on AI-powered medical imaging solutions, and introduced a new point-of-care (POC) diagnostic method in August 2022. This technique leverages a battery-powered X-ray machine for diagnosing tuberculosis. These AI-enhanced algorithms contribute to effective testing programs while ensuring exceptional portability, precision, and efficacy in point-of-care diagnostic solutions.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

What Are the Major Segments of the Tuberculosis Diagnostics Market and Their Role in Driving Growth?

The tuberculosis diagnostics market covered in this report is segmented –

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types

2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis

3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

Subsegments:

1) By Radiographic Tests: Chest X-rays, CT Scans

2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)

3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)

4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays

5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)

6) By Blood Or Serology Test: Serological Tests for Antibodies

7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test

8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures

9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques

Which Geographic Areas Are Influencing the Growth of the Tuberculosis Diagnostics Market?

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Core Features That Define the Tuberculosis Diagnostics Market?

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for TB diagnosis and tracking the effectiveness of treatment. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

Browse Through More Similar Reports By The Business Research Company:

Respiratory Disposables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report

Transplant Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Molecular Diagnostics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: